Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank77
3Y CAGR-29.1%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-29.1%/yr
Annual compound
Percentile
P77
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.88 | +143.1% |
| 2024 | 0.77 | -87.8% |
| 2023 | 6.34 | +20.4% |
| 2022 | 5.26 | -92.7% |
| 2021 | 72.58 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |